Effects of CAPAH, memantine, and rivastigmine on behavioral and cognitive functions of rats
Relevance. Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive and behavioral disorders. The drugs currently used in clinical practice can slow drug development but are usually associated with lifelong use because of the complexity of pathogenesis. Therefore, to correc...
Saved in:
| Main Authors: | D. O. Nikitin, I. I. Semina, A. V. Valeeva, A. V. Nikitina, A. Z. Khafizova, A. G. Ovchinnikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2024-11-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/426 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chronic intermittent hypoxia‐mediated cognitive dysfunction in ovariectomized rats
by: Emily C. Cheung, et al.
Published: (2025-08-01) -
EXPERIENCE WITH THE DRUG MEMANTINE IN PATIENTS WITH FOCAL EPILEPSY AND COGNITIVE IMPAIRMENT
by: Yu. V. Solomatin, et al.
Published: (2016-05-01) -
Conducting and automating the water Morris maze test in SPF conditions
by: N. V. Khotskin, et al.
Published: (2015-12-01) -
Nose to brain delivery of nanostructured lipid carriers loaded with rivastigmine and nilotinib for treating Alzheimer’s disease: preparation, cell line study, and in vivo evaluation
by: Saif Ahmad Khan, et al.
Published: (2025-06-01) -
Corrigendum: Differential timing of mitochondrial activation in rat dorsal striatum induced by procedural learning and swimming
by: Rogelio Pegueros-Maldonado, et al.
Published: (2025-03-01)